BDR Pharmaceuticals
Anand Bagaria is an accomplished financial executive with extensive experience in the pharmaceutical sector. Currently serving as Group CFO at BDR Pharmaceuticals since October 2023, Anand has previously held key finance positions at J. B. Chemicals & Pharmaceuticals Limited and Cipla, where responsibilities included overseeing significant P&L management, financial planning, and cross-functional partnerships. Anand's career also includes a tenure at IMS Consulting Group, providing strategic consulting for global healthcare organizations, and equity research roles in leading firms such as Irevna and Finquest Securities. Anand holds multiple degrees and executive education certifications, including a recent completion of the Strategic Leadership program from the Indian School of Business.
BDR Pharmaceuticals
Established in 2002 into API manufacturing, we have a consolidated position in the domestic and global market for the API Business. In today’s dynamic global pharmaceutical market, we at BDR Pharmaceuticals have carved a niche for ourselves, with our formulations portfolio for specialty medication. Our unique strategy of multi-branding ensures that critical and lifesaving medicines are available at affordable prices with two API and formulation facilities at Gujarat, Uttarakhand and a pellet facility at Hyderabad.